A Study to Assess the Safety, Dose Conversion, and Dose Individualization of Duragesic® (Fentanyl Transdermal Patch) in the Treatment of Children With Chronic Pain Requiring Narcotic Pain Relief Therapy
Clinical trial NCT00271466 · COMPLETED
Trial details
- NCT number
- NCT00271466
- Sponsor
- Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2000-02-01
- Enrollment
- 199
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.